In prostate cancer, it is reported that elevated LIMK1 is positively associated with higher Gleason Scores and incidence of metastasis, as well as poor clinical outcome and reduced survival (Davila et al., 2007; Mardilovich et al., 2015; Huang et al., 2020). The gene discussed is LIMK1; the disease is prostate cancer.